Over 5 Million Americans Could Benefit If Psilocybin Approved for Depression: Study
The result: In the mid-range of estimates, anywhere from 56% to 62% of Americans currently being treated for depression could be eligible to try psilocybin. That's anywhere from 5.1 million to 5.6 million potential patients, according to the researchers.